维普中文期刊产品整合服务
48篇 您的检索式:作者名="Meijerman"
    题名 作者 年代 出处 被引量
1An update on invitro test methods in human hepatic drug biotransformation research:pros and cons显示文摘Brandon E F Raap C D Meijerman I 2003Toxicol Appl Pharmacol2003,189,3:1
2显示文摘Blom WM De Bont Meijerman I 1999nepatology1999,29,3:1
3Nuclear receptor mediated induction of eytochrome P450 3A4 by anticaneer drugs:a key role for the pregnane X receptor显示文摘Harmsen S Meijerman I 2009Cancer Chemother Pharmacol2009,64,1:1
4In-vitro cytotoxicity of ET-743 (Trebectedin, Yondelis) , a marine anti-cancer drug, in the HepG2 cell line: influence of cytochrome P450 and phase II inhibition, and cytochrome P450 induction 显示文摘Brandon E F Meijerman I Klijin J S 2005Anticancer Drugs2005,16,9:1
5Remodeling of the actin cytosleleton of target hepatocytes and NK cells during induction apoptosis 显示文摘Blom WM de Bont HJ Meijerman 2001Cell Motility and the Cytoskeleton2001,49,:1
6Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer显示文摘Bosch T M Meijerman I Beijnen J H Schellens J H 2006Clin Pharmacokinet2006,45,3:1
7An update on in vitro test methods in human hepatic drug biotransformation research:Pros andcons显示文摘Brandon EFA Raap CD Meijerman I 2003Toxicology and Applied Pharmacology2003,,189:1
8Herb-drug interactions in oncology: focus on mechanisms of induction 显示文摘Meijerman I Beijnen JH Schellens JH 2006Oncologist2006,11,7:1
9The effect of grape seed extract on the pharmacokinetics of dextromethorphan in healthy volunteers显示文摘GOEY A K L MEIJERMAN I BEIJNEN J H 2013Eur J Clin Pharmacol2013,69,11:1
10Combined action and regulation of phase II enzymes and multidrug resistance proteins in multidrug resistance in cancer显示文摘Meijerman I Beijnen J H Schellens J H 2008Cancer Treatment Reviews2008,34,6:1
11Herb-drug interactions in ontology:focus on mechanisms of induction显示文摘Meijerman I Beijnen JH Schellensa JH 2006Oncologist2006,11,7:1
12Genetic poly- morphisms of drug-metabolizing enzymes and drug transporters in the chemotherapeutic treatment of cancer显示文摘BOSCH TM MEIJERMAN I BEIJNEN JH 2006Clin Pharmacoki- net2006,45,3:1
13The role of nuclearreceptors in phar macokinetic d r ug–d r ug interactions inoncology显示文摘Harmsen S Meijerman I Beijnen JH 2007Cancer Treat Rev2007,33,36:1
14In vitro cytotoxicity of ET-743 ( trabectedin, Yondelis), a marine anti-cancer drug, in the Hep G2 cell line : influence of cytochrome P450 and phase Ⅱ inhibition, and cytochrome P450 induction 显示文摘Brandon EF Meijerman I Klijin JS 2005Anticancer Drugs2005,16,9:1
15Identification of African stemborer larvae(Lepidoptera:Noctuidae,Pyralidae)based on morphology显示文摘MEIJERMAN L ULENBERG S A 1996Bull Ent Res1996,86,:1
16In vitro characterization of the biotransformation of thiocoraline, a novel marine anti-cancer drug 显示文摘Brandon E F Sparidans R W Meijerman I 2004Invest New Drugs2004,22,3:1
17Herb-drug interactions in ontology: focus on mechanisms of induction 显示文摘Meijerman I Beijnen J H Schellens J H M 2006Oncologist2006,11,:1
18An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons 显示文摘Brandon E F A Raap C D Meijerman I 2003Toxicol Appl Pharmacol2003,189,:1
19Herb-drug interactions in oncology:focus on mechanisms of induction显示文摘MEIJERMAN I BEIJNEN JH SCHELLENS JH 2006Oncologist2006,11,7:1
20The role of nu- clear receptors in pharmacokinefic drug - drug interactionsin oncology 显示文摘Harmsen S Meijerman I Beijnen JH 2007Cancer Treat2007,33,4:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费